Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Apr 05, 2024

SELL
$24.4 - $41.3 $2.1 Million - $3.56 Million
-86,086 Closed
0 $0
Q3 2022

Apr 05, 2024

SELL
$28.48 - $52.59 $54,510 - $100,657
-1,914 Reduced 2.18%
86,086 $2.45 Billion
Q2 2022

Apr 05, 2024

SELL
$36.95 - $82.41 $443,400 - $988,920
-12,000 Reduced 12.0%
88,000 $3.98 Billion
Q1 2022

Apr 05, 2024

BUY
$55.7 - $145.79 $5.57 Million - $14.6 Million
100,000 New
100,000 $7.61 Billion
Q4 2021

Apr 05, 2024

SELL
$135.05 - $182.59 $540,200 - $730,360
-4,000 Closed
0 $0
Q3 2021

Apr 05, 2024

BUY
$145.58 - $192.14 $582,320 - $768,560
4,000 New
4,000 $582 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.78B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.